Glioblastomas (GBMs) are the most common and aggressive tumors of the brain with aberrant resistance to therapies. MicroRNAs (miRs) are small non-coding RNAs that simultaneously suppress and/or activate the expression of multiple protein-encoding genes, and in so doing affect numerous cellular behaviors. Wnt pathway is of fundamental importance to development, tissue self-renewal and repair, cancer occurrence and progression. In GBM, miRs and Wnt signaling are dysregulated and contribute to tumor malignancies and therapeutic resistance. Glioma stem cells (GSC) are a cell subpopulation of primary GBM possess stem cell- like properties and is a key factor in glioma tumor recurrence and therapy resistance. We examined patient-derived GSCs displaying proneural (PN)- and mesenchymal (Mes)-like phenotypes of GBM, and found distinct molecular, biological, and therapeutic response characteristics in each. We also observed that in PN-like GSC relative to Mes-like GSC, two miRs, miR-125b and miR-20b are expressed at substantially high levels and that Wnt signaling is enriched. In vitro and in vivo studies demonstrated that miR-125b and -20b modulate GSC tumor phenotypes. Significantly, there is a positive feedback loop in GSC where Wnt induces miR-125b and -20b while miR-125b/-20b target Wnt inhibitors APC and FZD6, enhancing Wnt activity. Moreover, radiation of GSC induced Mes-like phenotypes, attenuated Wnt pathway and decreased levels of miR-125b and -20b. Based on these novel observations, we hypothesize that miR-125b, -20b and Wnt pathway form a positive feedback loop in GBM, and this interaction regulates malignant behaviors as well as radiation-induced Mes-like GBM phenotypes. To test this hypothesis, we propose to 1) define mechanisms by which miR-125b, miR-20b and Wnt signaling positively influence each other, and in so doing affect GSC malignant phenotypes; 2) determine whether miR-125b and miR-20b regulates GSC malignant phenotypes through Mes- associated genes in a dependent vs. an independent manner and 3) determine whether modulation of miR-125b/-20b and Wnt signaling regulates radiation-induced Mes-associated gene expression and phenotypes, and affects GBM tumor response to therapies. Our studies will help address an existing deficiency in understanding of how aberrant miR expression and Wnt signaling activity contribute to glioma malignancy. This knowledge, in turn, could lead to the identification of novel targets and more effective therapies for treating malignant gliomas.

Public Health Relevance

Glioma stem cells (GSC) are a small subpopulation in glioblastoma (GBM) that possess stem cell-like properties and contribute to GBM malignancy and resistance to therapies. MicroRNAs (miRs) and Wnt signaling are known to modulate malignant phenotypes of GBM and GSC. This application will test a hypothesis that a positive feedback interaction of Wnt and miR-125b, miR- 20b regulate phenotypes of GBM and that this interaction regulates malignant behaviors as well as radiation-induced GBM phenotypes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS093843-04
Application #
9502418
Study Section
Cancer Molecular Pathobiology Study Section (CAMP)
Program Officer
Fountain, Jane W
Project Start
2015-09-01
Project End
2020-05-31
Budget Start
2018-06-01
Budget End
2019-05-31
Support Year
4
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Neurology
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Bell, Jonathan B; Eckerdt, Frank; Dhruv, Harshil D et al. (2018) Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation. Mol Cancer Res 16:32-46
Sang, Youzhou; Li, Yanxin; Song, Lina et al. (2018) TRIM59 Promotes Gliomagenesis by Inhibiting TC45 Dephosphorylation of STAT3. Cancer Res 78:1792-1804
Wang, Wei; Zhang, Honghong; Liu, Sali et al. (2017) Internalized CD44s splice isoform attenuates EGFR degradation by targeting Rab7A. Proc Natl Acad Sci U S A 114:8366-8371
Xing, Fan; Luan, Yizhao; Cai, Jing et al. (2017) The Anti-Warburg Effect Elicited by the cAMP-PGC1? Pathway Drives Differentiation of Glioblastoma Cells into Astrocytes. Cell Rep 18:468-481
Huang, Tianzhi; Kim, Chung Kwon; Alvarez, Angel A et al. (2017) MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastoma. Cancer Cell 32:840-855.e8
Lv, Deguan; Li, Yanxin; Zhang, Weiwei et al. (2017) TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma. Nat Commun 8:1454
Lv, Deguan; Jia, Feng; Hou, Yanli et al. (2017) Histone Acetyltransferase KAT6A Upregulates PI3K/AKT Signaling through TRIM24 Binding. Cancer Res 77:6190-6201
Hashizume, Rintaro; Zhang, Ali; Mueller, Sabine et al. (2016) Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth. Neuro Oncol 18:1519-1528
Eckerdt, Frank; Alvarez, Angel; Bell, Jonathan et al. (2016) A simple, low-cost staining method for rapid-throughput analysis of tumor spheroids. Biotechniques 60:43-6
Huang, Tianzhi; Alvarez, Angel A; Pangeni, Rajendra P et al. (2016) A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways. Nat Commun 7:12885

Showing the most recent 10 out of 18 publications